FirstVitals® is redefining the future of gastrointestinal diagnostics with a bold, AI-first approach to Video Capsule Endoscopy (VCE). We plan to lead and expand this emerging market.
‍
As the first mover in AI-powered VCE across humans, companion pets, and large animals, FirstVitals® is unlocking a new frontier in multi-species diagnostics. Our proprietary platform will seamlessly integrate wireless capsule endoscopy with real-time AI interpretation, enabling non-invasive, accurate, scalable gastro-intestinal (“GI”)  imaging that transformsearly disease detection.
‍
In human healthcare, our AI-enhanced platform will improve accuracy, reduce bottlenecks, and will expand access to care, particularly in rural and underserved areas. We will go further with our veterinary solutions, bringing the same advanced technology to dogs, cats, and elite performance horses-meeting a high-margin, urgent diagnostic need in markets with little direct competition.

Investors have a rare window to join this paradigm shift. With a platform bridging human and veterinary medicine, a rapidly expanding addressable market , and proprietary IP across AI and capsule technology, FirstVitals® is positioned to lead a new category in precision diagnostics.

The race to lead AI in GI imaging has already begun. Will you join the company shaping the future, or watch from the sidelines?

Human Health
Precision GI Diagnostics, Accessible and AI-Powered.
The human GI market faces persistent bottlenecks: limited specialist availability, delays in endoscopy scheduling, and high procedural costs. ProteusDx™ will transform GI care with an FDA-cleared capsule platform enhanced by AI, delivering accurate detection of GERD, ulcers, and other GI conditions, without the need for sedation or scoping.
‍
But we’re not stopping at diagnostics. By enabling earlier treatment, better outcomes, and lower costs, ProteusDx™ supports the shift toward outpatient and remote care models. As healthcare moves to meet rising demand for scalable, patient-friendly solutions, ProteusDx™ empowers clinics and health systems to deliver fast, non-invasive GI care anywhere.

Companion Pets
Advanced, Non-Invasive GI Diagnostics for Dogs and Cats
Diagnosing GI conditions in pets is challenging. Traditional endoscopy is invasive, costly, and often unavailable, leaving many cases undiagnosed or delayed. ProteusDx™ changes this with a smart, capsule-based platform designed specifically for dogs and cats, with the ability to scan the entire GI track, detecting ulcers, IBD, tumors, and motility disorders through AI-powered image analysis.

With no need for sedation or specialty referrals, ProteusDx™ will empower veterinarians to deliver faster, accurate diagnostics directly in practice. This high-margin, consumer-pay market is ripe for disruption, with pet owners willing to invest in advanced care and no direct competitors offering smart capsule diagnostics at scale.

Equine
Advancing Equine GI Health with Precision Diagnostics
Up to 90% of performance horses suffer from gastric ulcers, yet traditional diagnosis is invasive, costly, and often inaccessible. ProteusDx™ Equine will offer a safe, swallowable capsule platform that detects ulcers, delivers targeted therapy, and monitors healing conveniently, without sedation or scoping.

This enables trainers, breeders, and owners to optimize performance and wellness proactively, supporting the health and careers of elite equine athletes. Serving a high-value, self-pay market with rapid adoption cycles, ProteusDx™ Equine is positioned to redefine standards of care in equine GI health.